Detecting the patient at risk of heart failure.

[1]  Yongmei Liu,et al.  Inflammatory Markers and Incident Heart Failure Risk in Older Adults: The Health, Aging, and Body Composition Study , 2009 .

[2]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[3]  J. Cohn,et al.  Time to foster a rational approach to preventing cardiovascular morbid events. , 2008, Journal of the American College of Cardiology.

[4]  P. Wilson,et al.  Incident Heart Failure Prediction in the ElderlyCLINICAL PERSPECTIVE , 2008 .

[5]  Tamara B Harris,et al.  Incident Heart Failure Prediction in the Elderly: The Health ABC Heart Failure Score , 2008, Circulation. Heart failure.

[6]  J. Cohn,et al.  Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study. , 2007, Journal of the American College of Cardiology.

[7]  Paul M. Ridker,et al.  Inflammation as a Cardiovascular Risk Factor , 2004, Circulation.

[8]  P. Ridker.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.

[9]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[10]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.